Is there any future for tumor necrosis factor antagonists in chronic heart failure?
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D002908:Chronic Disease; D003424:Crohn Disease / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000502:physiology / Q000627:therapeutic use; D005544:Forecasting; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000502:physiology / Q000627:therapeutic use*
D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha